down arrow

Concord Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE858L01010
  • NSEID:
  • BSEID: 538965
INR
31.87
0.87 (2.81%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.18 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

29.8033.49

52 Week

26.1044.96
Valuation
Technical
Day's Volume

CASH

1.18 k (-8.53%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

54.39%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -6.24% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.10 times
  • The company has been able to generate a Return on Equity (avg) of 2.50% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 33 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.56

stock-summary
Return on Equity

-1.51%

stock-summary
Price to Book

0.92

Revenue and Profits (1 Year):
Net Sales:
11 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-13.86%
0%
-13.86%
1 Year
-17.8%
0%
-17.8%
2 Years
9.37%
0%
9.37%
3 Years
6.77%
0%
6.77%
4 Years
-6.26%
0%
-6.26%
5 Years
117.54%
0%
117.54%

Concord Drugs for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.78%
EBIT Growth (5y)
-6.24%
EBIT to Interest (avg)
1.36
Debt to EBITDA (avg)
3.16
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.28
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.47%
ROE (avg)
2.50%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
0.92
EV to EBIT
25.15
EV to EBITDA
14.59
EV to Capital Employed
0.95
EV to Sales
0.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.29%
ROE (Latest)
-1.51%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Nagi Reddy Seelam (28.61%)

Highest Public shareholder

Rajender Kumar Agarwal (1.69%)

Individual Investors Holdings

45.11%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -15.49% vs -5.54% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 195.83% vs -153.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.80",
          "val2": "12.78",
          "chgp": "-15.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.39",
          "val2": "0.63",
          "chgp": "120.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.23",
          "val2": "-0.24",
          "chgp": "195.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.87%",
          "val2": "4.93%",
          "chgp": "7.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 45.73% vs -37.13% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -93.33% vs 183.78% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.06",
          "val2": "16.51",
          "chgp": "45.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.70",
          "val2": "3.07",
          "chgp": "-44.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.92",
          "val2": "0.87",
          "chgp": "5.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.07",
          "val2": "1.05",
          "chgp": "-93.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.07%",
          "val2": "18.61%",
          "chgp": "-11.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 19.02% vs -26.39% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -62.96% vs -1.22% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.86",
          "val2": "29.29",
          "chgp": "19.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.09",
          "val2": "3.70",
          "chgp": "-16.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.42",
          "val2": "1.37",
          "chgp": "3.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.30",
          "val2": "0.81",
          "chgp": "-62.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.86%",
          "val2": "12.63%",
          "chgp": "-3.77%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -13.75% vs -11.80% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -52.53% vs -37.74% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.93",
          "val2": "52.09",
          "chgp": "-13.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.05",
          "val2": "4.59",
          "chgp": "-11.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.87",
          "val2": "1.71",
          "chgp": "9.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.47",
          "val2": "0.99",
          "chgp": "-52.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.02%",
          "val2": "8.81%",
          "chgp": "0.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
10.80
12.78
-15.49%
Operating Profit (PBDIT) excl Other Income
1.39
0.63
120.63%
Interest
0.50
0.50
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.23
-0.24
195.83%
Operating Profit Margin (Excl OI)
12.87%
4.93%
7.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -15.49% vs -5.54% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 195.83% vs -153.33% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
24.06
16.51
45.73%
Operating Profit (PBDIT) excl Other Income
1.70
3.07
-44.63%
Interest
0.92
0.87
5.75%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.07
1.05
-93.33%
Operating Profit Margin (Excl OI)
7.07%
18.61%
-11.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 45.73% vs -37.13% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -93.33% vs 183.78% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
34.86
29.29
19.02%
Operating Profit (PBDIT) excl Other Income
3.09
3.70
-16.49%
Interest
1.42
1.37
3.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.30
0.81
-62.96%
Operating Profit Margin (Excl OI)
8.86%
12.63%
-3.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 19.02% vs -26.39% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -62.96% vs -1.22% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
44.93
52.09
-13.75%
Operating Profit (PBDIT) excl Other Income
4.05
4.59
-11.76%
Interest
1.87
1.71
9.36%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.47
0.99
-52.53%
Operating Profit Margin (Excl OI)
9.02%
8.81%
0.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -13.75% vs -11.80% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -52.53% vs -37.74% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Concord Drugs Ltd stock-summary
stock-summary
Concord Drugs Ltd
Micro Cap
Pharmaceuticals & Drugs
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
Company Coordinates stock-summary
Company Details
Survey No 249 Brahmanapally V, Hayathnagar M Ranga Reddy Telangana : 501511
stock-summary
Tel: 91-40-24036379
stock-summary
http://www.concorddrugs.in
stock-summary
concorddrugsltd@gmail.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."